There’s an old Wall Street saying: “Don’t try to catch a falling knife.” Sage advice, but in recent weeks stocks have been falling like a thousand machetes. If you’re an investor, every buy decision made since October has likely had the same result – you’ve ended up bloodied. However, there...
Nothing like putting a million bucks where your mouth is. After a presentation yesterday at the JPMorgan healthcare conference yesterday, an analyst bad-mouthed medical device giant Medtronic Plc (MDT) and cut price targets. As the stock tumbled over 6%, Medtronic CEO Omar Ishrak went on television to defend his company and debunk critics. Then today he bought $1 million dollars of MDT on the open market.
A recent example of how insider trading analysis can support biotech investing decisions is the case of Sangamo Therapeutics (Nasdaq: SGMO). In the two trading days following a September 4 release of data from a clinical trial, SGMO shares of fell over 31%.
It's typically bullish when a corporate insider buys shares of his or her company. Insiders have knowledge about their companies that outsiders don't. But when multiple corporate insiders purchase their own stock at the same time, it's typically an even stronger buy signal. Such "cluster buying"...
Shareholders of Basic Energy Services (BAS) recently saw that stock’s price cut by a third over two days. However, three company insiders viewed the drop as a buying opportunity, significantly increasing personal holdings via open market purchases.
For the first time in a decade, there’s a whiff of real fear in the financial markets.  I’m not talking about the low-grade anxiety we’ve seen occasionally during the bull market, where investors worry about when to buy the dip. Over the last few days we’ve seen something different -- a deeper fear, fear that comes from not knowing if there is a bottom.
Paul S Levy, Chairman of the Board at Builders FirstSouce Inc. (Nasdaq:BLDR) significantly increased his stake in the building products manufacturer by 10%, buying 100,000 shares on Sept. 6 on the open market at $15.98.  According to a Form 4 filed with the SEC on Sept. 7, Levy increased his stake to 1,117,984 shares or about 1% of BLDR’s shares outstanding.
Hornbeck industries (NYSE: HOS) stock has been on a tear since July 3 when a group of insiders disclosed acquiring a total of 24,550 shares at $4.00. HOS closed at $5.21 on June 29.
On June 13, 2018, Elon Musk reported buying 72,500 shares of Tesla, Inc. (TSLA) at an average price of about $344, spending nearly $25 million. Tesla stock rallied about 7.5% over the next three days. But the big purchase by Musk begs the question: Is it usually profitable to follow famous CEOs into their own stocks when they buy shares?